Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 4 | 2015 | 18 | 1.500 |
Why?
|
| Vitamin D | 4 | 2015 | 45 | 1.350 |
Why?
|
| Cell Differentiation | 10 | 2015 | 101 | 1.300 |
Why?
|
| Transforming Growth Factor beta | 10 | 2008 | 55 | 1.240 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 23 | 1.160 |
Why?
|
| Muscle, Skeletal | 12 | 2011 | 75 | 0.950 |
Why?
|
| Animals | 25 | 2019 | 1875 | 0.810 |
Why?
|
| Muscle Development | 4 | 2012 | 19 | 0.810 |
Why?
|
| Myostatin | 10 | 2011 | 23 | 0.640 |
Why?
|
| Vitamin D Deficiency | 2 | 2011 | 24 | 0.630 |
Why?
|
| Mice | 15 | 2012 | 746 | 0.560 |
Why?
|
| Mesoderm | 3 | 2008 | 15 | 0.560 |
Why?
|
| Cardiovascular Diseases | 2 | 2011 | 172 | 0.550 |
Why?
|
| Penis | 5 | 2019 | 41 | 0.480 |
Why?
|
| Muscle Fibers, Skeletal | 3 | 2012 | 10 | 0.480 |
Why?
|
| Gene Expression | 5 | 2012 | 77 | 0.470 |
Why?
|
| Heart | 1 | 2015 | 25 | 0.470 |
Why?
|
| Cells, Cultured | 9 | 2019 | 234 | 0.440 |
Why?
|
| Fibrosis | 3 | 2011 | 53 | 0.440 |
Why?
|
| Cholecalciferol | 1 | 2014 | 8 | 0.430 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 13 | 0.430 |
Why?
|
| Cell Proliferation | 3 | 2011 | 143 | 0.430 |
Why?
|
| Apoptosis | 4 | 2018 | 179 | 0.420 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 8 | 0.380 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 8 | 0.360 |
Why?
|
| Myoblasts | 2 | 2008 | 7 | 0.330 |
Why?
|
| Adipocytes | 3 | 2005 | 31 | 0.330 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 4 | 2019 | 9 | 0.320 |
Why?
|
| Cell Shape | 1 | 2010 | 3 | 0.320 |
Why?
|
| Cell Cycle | 1 | 2010 | 16 | 0.320 |
Why?
|
| Health Status Disparities | 1 | 2011 | 83 | 0.310 |
Why?
|
| Cell Line | 7 | 2012 | 124 | 0.310 |
Why?
|
| Cardiovascular System | 1 | 2009 | 21 | 0.300 |
Why?
|
| Receptors, Androgen | 5 | 2008 | 20 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2011 | 120 | 0.290 |
Why?
|
| Collagen | 1 | 2008 | 31 | 0.290 |
Why?
|
| Piperazines | 3 | 2014 | 21 | 0.280 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 27 | 0.280 |
Why?
|
| Fibroblasts | 1 | 2008 | 53 | 0.270 |
Why?
|
| Receptors, Calcitriol | 3 | 2014 | 16 | 0.270 |
Why?
|
| Kidney Diseases | 1 | 2009 | 121 | 0.270 |
Why?
|
| Testosterone | 5 | 2005 | 50 | 0.260 |
Why?
|
| Signal Transduction | 6 | 2012 | 246 | 0.250 |
Why?
|
| RNA, Messenger | 6 | 2012 | 190 | 0.240 |
Why?
|
| Rats | 8 | 2018 | 571 | 0.230 |
Why?
|
| Cell Nucleus | 4 | 2014 | 38 | 0.230 |
Why?
|
| Recombinant Proteins | 5 | 2008 | 45 | 0.210 |
Why?
|
| Follistatin | 3 | 2008 | 18 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2007 | 90 | 0.190 |
Why?
|
| Mice, Inbred C3H | 4 | 2008 | 39 | 0.190 |
Why?
|
| Cyclic GMP | 2 | 2019 | 22 | 0.180 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 6 | 0.180 |
Why?
|
| Nitric Oxide | 2 | 2019 | 47 | 0.180 |
Why?
|
| Male | 14 | 2019 | 3671 | 0.180 |
Why?
|
| Sulfones | 2 | 2012 | 10 | 0.180 |
Why?
|
| Citrulline | 2 | 2019 | 10 | 0.180 |
Why?
|
| Dietary Supplements | 2 | 2011 | 44 | 0.160 |
Why?
|
| Arginine | 1 | 2019 | 20 | 0.150 |
Why?
|
| RNA, Small Interfering | 3 | 2008 | 26 | 0.150 |
Why?
|
| Humans | 9 | 2015 | 6794 | 0.150 |
Why?
|
| MyoD Protein | 2 | 2011 | 3 | 0.140 |
Why?
|
| Protein Transport | 3 | 2014 | 23 | 0.140 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2008 | 20 | 0.140 |
Why?
|
| Ginger | 1 | 2018 | 2 | 0.140 |
Why?
|
| Olacaceae | 1 | 2018 | 2 | 0.140 |
Why?
|
| Paullinia | 1 | 2018 | 2 | 0.140 |
Why?
|
| Glucocorticoids | 3 | 2003 | 65 | 0.140 |
Why?
|
| Time Factors | 2 | 2008 | 321 | 0.130 |
Why?
|
| beta Catenin | 2 | 2008 | 15 | 0.130 |
Why?
|
| Androgens | 2 | 2008 | 24 | 0.120 |
Why?
|
| Blotting, Western | 3 | 2007 | 110 | 0.120 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 231 | 0.120 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 118 | 0.110 |
Why?
|
| Ganglia | 1 | 2014 | 2 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2014 | 17 | 0.110 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 15 | 0.110 |
Why?
|
| Oxidative Stress | 1 | 2014 | 102 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 2 | 2003 | 6 | 0.100 |
Why?
|
| Dexamethasone | 3 | 2003 | 30 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2019 | 282 | 0.100 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2012 | 3 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2012 | 4 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 34 | 0.090 |
Why?
|
| Ganglia, Autonomic | 1 | 2012 | 2 | 0.090 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 2012 | 2 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2014 | 94 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 30 | 0.090 |
Why?
|
| Transfection | 3 | 2007 | 56 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 14 | 0.090 |
Why?
|
| Organ Size | 3 | 2007 | 31 | 0.090 |
Why?
|
| Growth Differentiation Factors | 1 | 2011 | 2 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 7 | 0.090 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 8 | 0.090 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 14 | 0.080 |
Why?
|
| Vitamins | 1 | 2011 | 14 | 0.080 |
Why?
|
| Base Sequence | 3 | 2006 | 65 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 2011 | 22 | 0.080 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 2 | 0.080 |
Why?
|
| Genes, cdc | 1 | 2010 | 3 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2010 | 3 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 29 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2007 | 59 | 0.080 |
Why?
|
| Adult | 4 | 2009 | 2113 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 44 | 0.080 |
Why?
|
| TCF Transcription Factors | 2 | 2008 | 4 | 0.080 |
Why?
|
| Nutrition Policy | 1 | 2009 | 6 | 0.080 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2009 | 5 | 0.080 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2008 | 2 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2008 | 4 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 4 | 0.070 |
Why?
|
| Serpins | 1 | 2008 | 5 | 0.070 |
Why?
|
| Eye Proteins | 1 | 2008 | 10 | 0.070 |
Why?
|
| Sildenafil Citrate | 3 | 2014 | 9 | 0.070 |
Why?
|
| Purines | 3 | 2014 | 10 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2009 | 167 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2009 | 197 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 10 | 0.070 |
Why?
|
| Ethanol | 1 | 2008 | 86 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2008 | 73 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 57 | 0.070 |
Why?
|
| Phenotype | 1 | 2008 | 91 | 0.070 |
Why?
|
| Rats, Inbred F344 | 3 | 2014 | 27 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 21 | 0.070 |
Why?
|
| Video Recording | 1 | 2007 | 7 | 0.070 |
Why?
|
| African Americans | 1 | 2011 | 264 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2007 | 15 | 0.070 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 22 | 0.070 |
Why?
|
| Stroke Volume | 1 | 2007 | 20 | 0.070 |
Why?
|
| United States | 1 | 2011 | 1019 | 0.060 |
Why?
|
| Risk Factors | 1 | 2009 | 767 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2006 | 7 | 0.060 |
Why?
|
| Body Composition | 2 | 2003 | 47 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2018 | 26 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2005 | 15 | 0.060 |
Why?
|
| Gestrinone | 1 | 2005 | 1 | 0.060 |
Why?
|
| Azacitidine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2005 | 53 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 23 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2005 | 69 | 0.060 |
Why?
|
| Muscle Proteins | 2 | 2003 | 13 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 4 | 0.060 |
Why?
|
| Hypogonadism | 1 | 2004 | 10 | 0.060 |
Why?
|
| Dihydrotestosterone | 1 | 2003 | 5 | 0.050 |
Why?
|
| Muscular Atrophy | 1 | 2003 | 9 | 0.050 |
Why?
|
| Nerve Tissue | 2 | 2014 | 5 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 8 | 0.050 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2002 | 5 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2002 | 10 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 25 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 27 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2001 | 7 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2019 | 8 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2019 | 6 | 0.040 |
Why?
|
| Nitrites | 1 | 2019 | 8 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2019 | 22 | 0.040 |
Why?
|
| Orchiectomy | 2 | 2008 | 8 | 0.030 |
Why?
|
| 3T3 Cells | 2 | 2005 | 12 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2014 | 2 | 0.030 |
Why?
|
| Penile Erection | 1 | 2014 | 9 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 14 | 0.030 |
Why?
|
| Transcriptome | 1 | 2014 | 31 | 0.030 |
Why?
|
| Cytokines | 1 | 2014 | 80 | 0.030 |
Why?
|
| Kinetics | 2 | 2004 | 69 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 40 | 0.030 |
Why?
|
| Reference Values | 2 | 2004 | 56 | 0.030 |
Why?
|
| Neurturin | 1 | 2012 | 2 | 0.020 |
Why?
|
| Organ Sparing Treatments | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pelvis | 1 | 2012 | 6 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2012 | 19 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 40 | 0.020 |
Why?
|
| Neurons | 1 | 2012 | 50 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 155 | 0.020 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2011 | 2 | 0.020 |
Why?
|
| Epiregulin | 1 | 2011 | 2 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2011 | 8 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2011 | 30 | 0.020 |
Why?
|
| Adolescent | 2 | 2003 | 869 | 0.020 |
Why?
|
| Transcription Factor 4 | 1 | 2008 | 3 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 5 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 5 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 25 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 258 | 0.020 |
Why?
|
| Electroporation | 1 | 2006 | 4 | 0.020 |
Why?
|
| Lac Operon | 1 | 2006 | 3 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2006 | 6 | 0.020 |
Why?
|
| Plasmids | 1 | 2006 | 17 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2006 | 13 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2006 | 19 | 0.020 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 17 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2003 | 12 | 0.010 |
Why?
|
| Stem Cells | 1 | 2003 | 19 | 0.010 |
Why?
|
| Tosyl Compounds | 1 | 2003 | 2 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 98 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2003 | 3 | 0.010 |
Why?
|
| Anilides | 1 | 2003 | 5 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 10 | 0.010 |
Why?
|
| Nitriles | 1 | 2003 | 13 | 0.010 |
Why?
|
| Mifepristone | 1 | 2003 | 8 | 0.010 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 25 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2003 | 258 | 0.010 |
Why?
|
| Body Weight | 1 | 2003 | 90 | 0.010 |
Why?
|
| Sex Factors | 1 | 2003 | 155 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2002 | 1 | 0.010 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2002 | 2 | 0.010 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2002 | 8 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2002 | 6 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2002 | 101 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 64 | 0.010 |
Why?
|
| DNA Probes | 1 | 2001 | 5 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 8 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2001 | 8 | 0.010 |
Why?
|
| Stimulation, Chemical | 1 | 2001 | 15 | 0.010 |
Why?
|
| Child | 1 | 2003 | 524 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 17 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 70 | 0.010 |
Why?
|
| Drosophila | 1 | 2001 | 3 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2001 | 8 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 7 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 11 | 0.010 |
Why?
|
| DNA | 1 | 2001 | 39 | 0.010 |
Why?
|
| Middle Aged | 1 | 2004 | 2108 | 0.010 |
Why?
|
| Female | 1 | 2003 | 4060 | 0.010 |
Why?
|